<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01284595</url>
  </required_header>
  <id_info>
    <org_study_id>D0102C00007</org_study_id>
    <nct_id>NCT01284595</nct_id>
  </id_info>
  <brief_title>Healthy Volunteers, Absorption, Distribution, Metabolism and Excretion (ADME) Study With Single Oral Administration of [14C] AZD8931</brief_title>
  <official_title>[14C] AZD8931 - A Phase I, Open Label Study of the Absorption, Metabolism, Excretion, and Pharmacokinetics Following a Single Oral Dose to Healthy Male Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AstraZeneca</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study to Assess the Absorption, Metabolism and Excretion of [14C]AZD8931 after a Single-Dose
      Oral Administration
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">May 2011</completion_date>
  <primary_completion_date type="Actual">May 2011</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To investigate the absorption, distribution, metabolism and excretion of AZD931 in human subjects</measure>
    <time_frame>Multiple blood , urine and faecal samples from pre-dose until 240 hours post last dose</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>To investigate the pharmacokinetic variable of AZD8931 in plasma</measure>
    <time_frame>Multiple PK blood samples from pre-dose until 240 hours post last dose</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To investigate the safety and tolerability of AZD8931 given orally</measure>
    <time_frame>Frequent safety measurements during the study from screening period to follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To investigate the AZD8931 metabolites variables in plasma</measure>
    <time_frame>Multiple PK blood samples from pre-dose until 240 hours post last dose</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">6</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>AZD8931</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>[14C] AZD8931</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>[14C] AZD8931</intervention_name>
    <description>Single 160 mg oral dose administered on Day 1</description>
    <arm_group_label>AZD8931</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Have a body mass index (BMI) of ≥19 and ≤30 kg/m2 and weight of ≥50 kg and ≤100 kg.

          -  Regular daily bowel movements (ie, production of at least 1 stool per day).

          -  Non-smokers or ex-smokers who have stopped smoking for &gt;3 months before Visit 1 and
             have not used nicotine products for &gt;3 months

          -  Healthy Male volunteers aged 50 to 65 years, inclusive

        Exclusion Criteria:

          -  Healthy volunteers who have been exposed to radiation levels above background (eg,
             through X-ray examination) of &gt;5 mSv in the last year, &gt;10 mSv in the last 5 years, or
             a cumulative total of &gt;1 mSv per year of life

          -  Participation in any prior radiolabelled study within 12 months of the screening visit
             (Visit 1).

          -  History of alcohol abuse or excessive intake of alcohol defined as regular weekly
             intake of 28 units of alcohol or more (1 unit=25 mL spirits, 125 mL wine, 250 mL beer
             or lager)
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Darren Wilbraham, MBBS, DCPSA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Quintiles Drug Research Unit at Guy's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mary Stuart</last_name>
    <role>Study Director</role>
    <affiliation>AstraZeneca</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&amp;studyid=1626&amp;filename=D0102C00007_Clinical_Study_Protocol_redacted_for_posting.pdf</url>
    <description>Clinical_Study_Protocol_redacted</description>
  </link>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 26, 2011</study_first_submitted>
  <study_first_submitted_qc>January 26, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2011</study_first_posted>
  <last_update_submitted>August 12, 2014</last_update_submitted>
  <last_update_submitted_qc>August 12, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 13, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Radioactive carbon</keyword>
  <keyword>Absorption</keyword>
  <keyword>Distribution</keyword>
  <keyword>Metabolism</keyword>
  <keyword>Excretion</keyword>
  <keyword>Healthy Volunteers</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

